GBC is committed to the research and development of new drugs.
Based on our ultimate spirit, GBC develops new drug candidates through our solid footstone and promotes health by promising and more effective medications for oncological, autoimmune, degenerative, metabolic and orphan diseases etc. We dedicate to advancing health and welfare in whole life.
view moreGoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Patients
This trial is a Phase 2 randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Antroquinonol in hospitalized patients with mild to moderate pneumonia due to COVID-19 (Coronavirus SARS-CoV-2 disease). The trial completed recruiting for 124 patients in the USA, Peru and Argentina where the new pandemic upheaval is rampant with highly transmitted SARS-CoV-2 variants.
view moreNews
view more- Jul 07, 2022
- Jan 07, 2022
- May 27, 2022
